Cdk9 Kinase Inhibitors

Abstract

Disclosed are compound of Formula (Ia), wherein R1A, R1, R2, R10, J, L, T, X, Y, and Z are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions, comprising one or more compounds of Formula (Ia).


Claims
Owners (US)
Download PDF
Document Preview
Document History
  • Publication: Mar 3, 2015
  • Application: Mar 13, 2014
    US US 201414207841 A
  • Priority: Mar 13, 2014
    US US 201414207841 A
  • Priority: Mar 13, 2013
    US US 201361780261 P

Download Citation


Sign in to the Lens

Feedback